Dapsone Responsive Pemphigus
VL Rege, Sehgal Vn, M. F. Mascarenhas
Abstract
VL Rege, Sehgal Vn, M. F. Mascarenhas
Abstract
A 45 year old female diagnosed clinically ,and histopathologically as a case of pemhigus responded well to prednisolone initially. The exacerbation of the condition on withdrawal of prednisolone could not be controlled even with sustained high dosage of prednisolone which led to multiple side effects. Dapsone in the dosage of 100 mg per day controlled the disease. The control of pemphigus in the patient by dapsone was further confirmed by withdrawal and reinstitution of the drug.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
A 45 year old female diagnosed clinically ,and histopathologically as a case of pemhigus responded well to prednisolone initially. The exacerbation of the condition on withdrawal of prednisolone could not be controlled even with sustained high dosage of prednisolone which led to multiple side effects. Dapsone in the dosage of 100 mg per day controlled the disease. The control of pemphigus in the patient by dapsone was further confirmed by withdrawal and reinstitution of the drug.
Key concepts: Dapsone, Prednisolone, Exacerbation, Medicine, Pemphigus, Drug, Dermatology, Pharmacology